Vironexis, OR, Vironexis Biotherapeutics

visited this project
a year ago
We are an early stage Biotech company specializing in Gene Therapies for Cancer. Target audience will be investors, industry leaders, large pharma companies, as well as individuals.
$199
STANDARD
179
ENTRIES
Open
Revisions
Winner
4
Complete